Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis

Clinical trial NCT00811395 · COMPLETED

Trial details

NCT number: NCT00811395
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2007-10-01
Primary completion: 2010-04-01
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.